Table 2.

Anatomopathological, clinical, and treatment characteristics of the studied sample[3,4]

	n	%
Tumor stage1 (n = 102)
0	1	0.98
1	30	29.41
2	18	17.64
3	33	32.35
4	20	19.60
Lymph node stage1 (n = 103)
0	59	57.28
1	21	20.38
2	12	11.65
3	11	10.67
Tumor grade (n = 96)
I	10	10.40
II	42	43.80
III	4	45.80
Helicobacter pylori (n = 64)
Positive	26	40.60
Negative	38	59.40
Lauren histopathological type (n = 101)
Diffuse	33	32.70
Intestinal	62	61.40
Mixed	6	05.90
Smoking (n = 102)
Yes	56	54.90
No	46	45.10
Alcoholism (n = 102)
Yes	17	16.70
No	85	83.30
Gastrectomy performed (n = 104)
Proximal	2	01.90
Total	38	36.50
Partial	64	61.50
Neoadjuvant treatment
Yes	23	22.10
No	81	77.90
Adjuvant treatment
Yes	36	35.60
No	65	64.40

¹Pathologic stage groups (pTNM).